These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30732990)

  • 1. Reply to 'Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature'.
    Wegner F; Müller-Ladner U; Meier FM
    J Clin Neurosci; 2019 May; 63():281. PubMed ID: 30732990
    [No Abstract]   [Full Text] [Related]  

  • 2. Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature.
    Ahmad AS; Tahir RA; Mitsias PD
    J Clin Neurosci; 2018 Oct; 56():177-179. PubMed ID: 30017593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Thyrotoxicosis of Graves Disease Associated with Moyamoya Vasculopathy and Stroke in Latin American Women: A Case Series and Review of the Literature.
    Shah NH; Khandelwal P; Gordon-Perue G; Shah AH; Barbarite E; Ortiz G; Forteza AM
    World Neurosurg; 2016 Aug; 92():95-107. PubMed ID: 27163552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya syndrome with antiphospholipid antibodies: a case report and literature review.
    Wang Z; Fu Z; Wang J; Cui H; Zhang Z; Zhang B
    Lupus; 2014 Oct; 23(11):1204-6. PubMed ID: 24939972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients.
    Vandergheynst F; Ocmant A; Sordet C; Humbel RL; Goetz J; Roufosse F; Cogan E; Sibilia J
    Clin Exp Rheumatol; 2006; 24(2):129-33. PubMed ID: 16762146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costello syndrome showing moyamoya-like vasculopathy.
    Shiihara T; Kato M; Mitsuhashi Y; Hayasaka K
    Pediatr Neurol; 2005 May; 32(5):361-3. PubMed ID: 15866441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-Scl-70 antibodies in systemic scleroderma].
    Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
    Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioplasty for acute stroke with pediatric moyamoya syndrome.
    El-Hakam LM; Volpi J; Mawad M; Clark G
    J Child Neurol; 2010 Oct; 25(10):1278-83. PubMed ID: 20505156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune antibody in moyamoya disease].
    Wanifuchi H; Kagawa M; Takeshita M; Izawa M; Maruyama S; Kitamura K
    No Shinkei Geka; 1986 Jan; 14(1):31-5. PubMed ID: 3485262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.
    Saarela M; Mustanoja S; Pekkola J; Tyni T; Hernesniemi J; Kivipelto L; Tatlisumak T
    Int J Stroke; 2017 Jan; 12(1):90-95. PubMed ID: 27625049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual association between lysinuric protein intolerance and moyamoya vasculopathy.
    Ghilain V; Wiame E; Fomekong E; Vincent MF; Dumitriu D; Nassogne MC
    Eur J Paediatr Neurol; 2016 Sep; 20(5):777-81. PubMed ID: 27321952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.
    Levine SR; Fagan SC; Pessin MS; Silbergleit R; Floberg J; Selwa JF; Vogel CM; Welch KM
    Neurology; 1991 Dec; 41(12):1893-901. PubMed ID: 1745344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting diseases of moyamoya vasculopathy.
    Wei YC; Liu CH; Chang TY; Chin SC; Chang CH; Huang KL; Chang YJ; Peng TI; Lee TH
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1344-50. PubMed ID: 24468071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population.
    Catoggio LJ; Skinner RP; Maddison PJ
    Rheumatol Int; 1983; 3(1):19-21. PubMed ID: 6412349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinfectious vasculopathy with evolution to moyamoya syndrome.
    Czartoski T; Hallam D; Lacy JM; Chun MR; Becker K
    J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):256-9. PubMed ID: 15654044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya syndrome causing stroke in young women with type 1 diabetes.
    Hughes JW; Wyckoff JA; Hollander AS; Derdeyn CP; McGill JB
    J Diabetes Complications; 2016; 30(8):1640-1642. PubMed ID: 27592246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association with birth control pills. Moyamoya.
    Sequeira W; Naseem M; Bouffard DA
    IMJ Ill Med J; 1984 Dec; 166(6):434-6. PubMed ID: 6150921
    [No Abstract]   [Full Text] [Related]  

  • 19. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.
    Spencer-Green G; Alter D; Welch HG
    Am J Med; 1997 Sep; 103(3):242-8. PubMed ID: 9316557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive stenosis and radiological findings of vasculitis over the entire internal carotid artery in moyamoya vasculopathy associated with graves' disease: a case report and review of the literature.
    Ito H; Yokoi S; Yokoyama K; Asai T; Uda K; Araki Y; Takasu S; Kobayashi R; Okada H; Okuda S
    BMC Neurol; 2019 Mar; 19(1):34. PubMed ID: 30825882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.